1 completed, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow Biliary Tract Cancer (CCA): new trials by email Literature Review of Biliary Tract Cancer (CCA) trials Research Report on Biliary Tract Cancer (CCA)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Single-arm, Multicenter, Exploratory Study of Adebrelimab Combined With Apatinib and Systemic Chemotherapy for Initially Unresectable Biliary Tract Cancer Adebrelimab combined with the GC regimen and Apatinib - Biliary Tract Cancer, Biliary Tract Cancer (CCA) | Phase 2 | Recruiting | Yongjun Chen | 37 | 2025-08-14 | 2025-08-22 |
| Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer Durvalumab, Tremelimumab, Capecitabine - Biliary Tract Cancer (CCA), Intrahepatic Cholangiocarcinoma | Phase 2 | Completed | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 40 | 2022-05-23 | 2025-05-01 |
Biliary Tract Neoplasms (2) · Cholangiocarcinoma (1) · Gallbladder Neoplasms (1) · Klatskin Tumor (1)
Biliary Tract Diseases (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Neoplasms (2) · Neoplasms by Site (2) · Adenocarcinoma (1) · Carcinoma (1) · Gallbladder Diseases (1) · Neoplasms by Histologic Type (1) · Neoplasms, Glandular and Epithelial (1)
Capecitabine (1) · apatinib (1) · durvalumab (1) · tremelimumab (1)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest (1) · Yongjun Chen (1)
China (1) · Germany (1)